Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs
Sign Up to like & getrecommendations! Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0280570
Abstract: Background Insurers manage the cost of specialty medicines via rebates, however it is unclear if the savings are passed on to patients, and whether reducing rebates may lead to changes in patient out-of-pocket (OOP) costs… read more here.
Keywords: patient oop; oop costs; list price; sofosbuvir ... See more keywords